tiprankstipranks
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
Holding PTGX?
Track your performance easily

Protagonist Therapeutics (PTGX) Income Statement

616 Followers

Protagonist Therapeutics Income Statement

Last quarter (Q3 2024), Protagonist Therapeutics's total revenue was $4.67M, an increase of Infinity% from the same quarter last year. In Q3, Protagonist Therapeutics's net income was $-33.21M. See Protagonist Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 323.80M$ 60.00M$ 26.58M$ 27.36M$ 28.63M$ 64.00K
Cost of Revenue
------
Gross Profit
$ 323.80M$ 60.00M$ 26.58M$ 27.36M$ 28.63M$ 64.00K
Operating Expense
$ 174.68M$ 153.65M$ 157.95M$ 153.20M$ 93.14M$ 80.75M
Operating Income
$ 149.11M$ -93.65M$ -131.37M$ -125.84M$ -64.52M$ -80.52M
Net Non Operating Interest Income Expense
$ 23.70M$ 14.90M$ 4.06M$ 443.00K$ 302.00K$ 2.64M
Other Income Expense
$ -665.00K$ -201.00K$ -80.00K$ 149.00K$ 631.00K$ 1.00K
Pretax Income
$ 173.08M$ -78.95M$ -127.39M$ -125.55M$ -64.84M$ -77.88M
Tax Provision
$ 2.23M---$ 1.30M$ -691.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 170.87M$ -78.95M$ -127.39M$ -125.55M$ -66.15M$ -77.19M
Basic EPS
$ 2.91$ -1.39$ -2.60$ -2.71$ -1.92$ -2.98
Diluted EPS
$ 2.76$ -1.39$ -2.60$ -2.71$ -1.92$ -2.98
Basic Average Shares
$ 244.45M$ 56.76M$ 49.04M$ 46.32M$ 34.40M$ 25.89M
Diluted Average Shares
$ 247.19M$ 56.76M$ 49.04M-$ 34.40M$ 25.89M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 174.68M$ 153.65M$ 157.95M$ 153.20M$ 93.14M$ 80.75M
Net Income From Continuing And Discontinued Operation
$ 170.85M$ -78.95M$ -127.39M$ -125.55M$ -66.15M$ -77.19M
Normalized Income
$ -44.43M$ -62.37M----
Interest Expense
------
EBIT
$ 164.43M$ -93.65M$ -131.37M$ -125.84M$ -64.25M$ -77.71M
EBITDA
$ 169.24M$ -90.34M$ -128.00M$ -123.07M$ -61.52M$ -75.81M
Currency in USD

Protagonist Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis